Add To Cart

Section 11
Opioid and Benzodiazepine Use Disorder

Question 11 | Test | Table of Contents

Indiana Family and Social Services Administration

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, click Ctrl + several times, then scroll.
Questions? Email: [email protected]

- Pence, M. R. (December 30, 2016). Best Practice Guidelines for the Treatment of Opioid Use Disorders. Indiana Family and Social Services Administration, 18-22.

Peer-Reviewed Journal Article References:
Aaron, R. V., Finan, P. H., Wegener, S. T., Keefe, F. J., & Lumley, M. A. (2020). Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use. American Psychologist, 75(6), 796–810.

MacLean, R. R., Sofuoglu, M., Stefanovics, E., & Rosenheck, R. (2021). Opioid use disorder with chronic pain increases disease burden and service use. Psychological Services. Advance online publication.

Mahoney, J. J. III, Haut, M. W., Hodder, S. L., Zheng, W., Lander, L. R., Berry, J. H., Farmer, D. L., Marton, J. L., Ranjan, M., Brandmeir, N. J., Finomore, V. S., Hensley, J. L., Aklin, W. M., Wang, G.-J., Tomasi, D., Shokri-Kojori, E., & Rezai, A. R. (2021). Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder. Experimental and Clinical Psychopharmacology, 29(2), 210–215.

What drug class presents an extremely high risk for adverse drug reaction involving overdose and/or death during the induction process? To select and enter your answer go to Test.

Section 12
Table of Contents